Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.

作者: Najim Ameziane , Ans M. W. van den Ouweland , Muriel A. Adank , Raymond N. C. P. Vijzelaar , Abdellatif Errami

DOI: 10.1007/S10549-009-0428-8

关键词: PALB2FANCAMutationCHEK2BRIP1Tumor suppressor genePTENGeneticsBiologyCancerCancer research

摘要: 16% of the familial BC cases [2]. Other sus-ceptibility genes include TP53 [16], PTEN [15], ATM [24],LKB1/STK11 [8], CHEK2 [28], BRIP1/FANCJ [27], andPALB2/FANCN [22]. However to date, majority offamilial can not be attributed mutations in oneof known susceptibility genes.The discovery breast cancer geneBRCA2asthegenedefectiveintheFanconianemia(FA)-D1complementation group [11], identification BRIP1(BRCA1 InteractingProtein)[3, 12,13] andPALB2 (PartnerAnd Localizer BRCA2) [23, 32] as responsiblefor FA-J and FA-N complementation groups, respec-tively, established a clear link between FA. Fanconi anemia (FA) is recessivelyinherited chromosomal instability syndrome with autosomalor X-linked mode inheritance, characterized by anincreased several forms malignancies [1,17].Thediseaseiscausedbymutationsinoneofthe13genesso far identified [18]. The FA gene products interact acommon pathway whereby most proteins (FANCA, -B, -C, -E, -F, -G, -L, -M) form multiprotein complexthat required for monoubiquitination FANCD2 andFANCI.However,thismodificationstepisnotinfluencedbyFANCD1(BRCA2),FANCJ(BRIP1),orFANCN(PALB2),and hence these seem act downstream thisprocess. FANCI are thought proteincomplex (ID complex), which translocates DNA damagesites where it co-localizes proteins,BRCA2/FANCD1, BRIP1/FANCJ, PALB2/FANCNand other that involved recognition andrepair damage, such BRCA1, ATM, NBS, andRAD51 [31].Several studies explored whether heterozygous femalecarriers mutation one atincreased risk cancer. To only inthe ‘‘downstream’’ have been found signifi-cantly elevate developing Het-erozygous PALB2/FANCNappear increase 2- 2.3-fold, respectively [22,27]. Risk assessment has based on screening fortruncating breastcancer (FBC) patients lacking BRCA1/2.Furthermore, mutations, suggested toplay role development onobservations Fancd2 knockout mice, demon-strated high incidence epithelial tumors, includingmammary ovarian tumors [10]. However, humans asignificant contribution FBCcould [14, 26].

参考文章(32)
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko, Alexander Miron, Qing Sheng, Guilan Li, Henna Mattila, Daphne W Bell, Daniel A Haber, Mervi Grip, Mervi Reiman, Arja Jukkola-Vuorinen, Aki Mustonen, Juha Kere, Lauri A Aaltonen, Veli-Matti Kosma, Vesa Kataja, Ylermi Soini, Ronny I Drapkin, David M Livingston, Robert Winqvist, None, A recurrent mutation in PALB2 in Finnish cancer families Nature. ,vol. 446, pp. 316- 319 ,(2007) , 10.1038/NATURE05609
María J García, Victoria Fernández, Ana Osorio, Alicia Barroso, Gemma LLort, Conxi Lázaro, Ignacio Blanco, Trinidad Caldés, Miguel De la Hoya, Teresa Ramón y Cajal, Carmen Alonso, María-Isabel Tejada, Carlos San Román, Luis Robles-Díaz, Miguel Urioste, Javier Benítez, None, Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families Breast Cancer Research and Treatment. ,vol. 113, pp. 545- 551 ,(2009) , 10.1007/S10549-008-9945-0
R.A. Oldenburg, H. Meijers-Heijboer, C.J. Cornelisse, P. Devilee, Genetic susceptibility for breast cancer: how many more genes to be found? Critical Reviews in Oncology Hematology. ,vol. 63, pp. 125- 149 ,(2007) , 10.1016/J.CRITREVONC.2006.12.004
C G Mathew, Fanconi anaemia genes and susceptibility to cancer Oncogene. ,vol. 25, pp. 5875- 5884 ,(2006) , 10.1038/SJ.ONC.1209878
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova, Lesley McGuffog, D Gareth Evans, Diana Eccles, Douglas F Easton, Michael R Stratton, Breast Cancer Susceptibility Collaboration (UK), Nazneen Rahman, None, ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nature Genetics. ,vol. 38, pp. 873- 875 ,(2006) , 10.1038/NG1837
Blanche P. Alter, Cancer in Fanconi anemia, 1927–2001 Cancer. ,vol. 97, pp. 425- 440 ,(2003) , 10.1002/CNCR.11046
Blanche P. Alter, Mark H. Greene, Isela Velazquez, Philip S. Rosenberg, Cancer in Fanconi anemia Blood. ,vol. 101, pp. 2072- 2072 ,(2003) , 10.1182/BLOOD-2002-11-3597
Wendy L Bridge, Cassandra J Vandenberg, Roger J Franklin, Kevin Hiom, The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair Nature Genetics. ,vol. 37, pp. 953- 957 ,(2005) , 10.1038/NG1627
Marc Tischkowitz, Nelly Sabbaghian, Anna M. Ray, Ethan M. Lange, William D. Foulkes, Kathleen A. Cooney, Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. The Prostate. ,vol. 68, pp. 675- 678 ,(2008) , 10.1002/PROS.20729